It contributes to the protection of cells from oxidative stress and plays a role in the maintenance of normal hair and nails.* *Authorised health claims per the EU Register of Nutrition and Health Claims
Whilst there is no direct pharmacological interaction documented in the SmPCs, the combination may present indirect risks that require monitoring and management
They'd only appear in the same program if it spans both domains
Current Opinion in Lipidology
The standard protocol begins with a 0.25 mg starting dose administered once weekly, then advances to 0.5 mg in week five, followed by 1.0 mg in week nine, and potentially reaching 2.0 mg or higher by week thirteen depending on individual tolerance
Eli Lilly may submit its dossier for first round evaluation after TRIUMPH-3 (pending positive outcomes), so at the earliest, late 2026 seems like a realistic estimation, if not later into early 2027 after TRIUMPH-5 has finished